Kidney Cancer

Latest News

April 15th 2013

Metastatic renal cell carcinoma agent nearly doubles survival

By Wayne Kuznar

A personalized immunotherapy (AGS-003) nearly doubled expected progression-free survival and overall survival when added to standard sunitinib (Sutent) in patients with unfavorable-risk metastatic renal cell carcinoma, according to results from a single-arm phase II study.

Novel VEGF inhibitor may play role in advanced renal cell carcinoma

By Wayne Kuznar

Treatment of metastatic renal cell carcinoma: What can we offer?

By Kyle Richards MD., Scott Eggener MD.

February 19th 2013

Study: Surveillance is safe for small renal masses

CME Content

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

Ana Kiess, MD, PhD; Erin Grady, MD, CCD, FACNM, FSNMMI; Himanshu Nagar, MD, MS; Scott T. Tagawa, MD, MS, FASCO, FACP

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Trending on Urology Times

AMA issues Category I CPT codes for implantable tibial neuromodulation in UUI

The UroOnc Minute: Key Updates to the AUA NMIBC Guideline, With Peter E. Clark, MD

Aglatimagene besadenovec shows sustained immune remodeling in localized prostate cancer

John Sfakianos, MD, on integrating ctDNA into bladder cancer trials

Closing Risk Stratification Gaps in Localized Prostate Cancer With AI